SheenaBhallaMD

PubMed

• Geographic Accessibility and Completion of Initial Low-Dose CT-Based Lung Cancer Screening in an Urban Safety-Net Population.
  Sofia Yi, Rutu A Rathod, Vijaya Subbu Natchimuthu, Sheena Bhalla, Jessica L Lee, Travis Browning, Joyce O Adesina, Minh Do, David Balis, Juana Gamarra de Wiliams, Elle...> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 23
• Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable Populations.
  Sheena Bhalla, Vijaya Natchimuthu, Jessica L Lee, Urooj Wahid, Hong Zhu, Noel O Santini, Travis Browning, Heidi A Hamann, David H Johnson, Hsienchang Chiu, Simon J Cra...> ;Journal of the National Comprehensive Cancer Network. 2024 Mar 15
• Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer.
  David E Gerber, Yating Wang, Suresh S Ramalingam, Sheena Bhalla, Zhuoxin Sun, Hossein Borghaei, Julie R Brahmer, Joan H Schiller> ;The Oncologist. 2024 Apr 4
• Emerging Strategies in Lung Cancer Screening: Blood and Beyond.
  Sheena Bhalla, Sofia Yi, David E Gerber> ;Clinical Chemistry. 2024 Jan 4
• Contemporary Trends in Reviewing Test Results Through the Electronic Patient Portal Among Patients With Cancer.
  Sheena Bhalla, Tanushree Prasad, Donglu Xie, David E Gerber> ;JAMA Oncology. 2024 Jan 1
• 4 citations
  Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer.
  Sheena Bhalla, Farjana J Fattah, Chul Ahn, Jessica Williams, Alyssa Macchiaroli, Jonathan Padro, Meredith Pogue, Jonathan E Dowell, William C Putnam, Nigel McCracken, ...> ;Lung Cancer. 2023 Aug 1
• 2 citations
  Assessing Barriers and Facilitators to Lung Cancer Screening: Initial Findings from a Patient Navigation Intervention.
  Simon J Craddock Lee, Jessica Lee, Hong Zhu, Patricia M Chen, Urooj Wahid, Heidi A Hamann, Sheena Bhalla, Rodrigo Catalan Cardenas, Vijaya Subbu Natchimuthu, David H J...> ;Population Health Management. 2023 Jun 1
• 9 citations
  AXL Inhibitors: Status of Clinical Development.
  Sheena Bhalla, David E Gerber> ;Current Oncology Reports. 2023 May 1
• 11 citations
  Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.
  Sheena Bhalla, Ziad Bakouny, Andrew Schmidt, Chris Labaki, John A. Steinharter, Douglas Tremblay, Mark M. Awad, Alaina J. Kessler, Robert I. Haddad, Michelle Evans, Fi...> ;Lung Cancer. 2021 Jul 16
• 3 citations
  Impact of pathological response after neoadjuvant chemotherapy on adjuvant therapy decisions and patient outcomes in gastrointestinal cancers.
  Sheena Bhalla, Huili Zhu, Jung-Yi Lin, Umut Ozbek, Eric J. Wilck, Xiuxu Chen, Stephen C. Ward, Noam Harpaz, Alexandros D. Polydorides, William Miller, Maria Isabel Fie...> ;Cancer Reports. 2021 May 25
• 602 citations
  PD-L1 as a biomarker of response to immune-checkpoint inhibitors
  Deborah B. Doroshow, Sheena Bhalla, Mary Beth Beasley, Lynette M. Sholl, Keith M. Kerr, Sacha Gnjatic, Ignacio I. Wistuba, David L. Rimm, Ming-Sound Tsao, Fred R. Hirsch> ;Nature Reviews. Clinical Oncology. 2021 Feb 12
• 69 citations
  Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.
  Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina J. Kessler, Sangeetha Venugopal, Iman Makki, Qian Qin,...> ;Thrombosis Research. 2020 Dec 1
• 46 citations
  Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.
  Andrew Schmidt, Ziad Bakouny, Sheena Bhalla, John A. Steinharter, Douglas Tremblay, Mark M. Awad, Alaina J. Kessler, Robert I. Haddad, Michelle Evans, Fiona Busser, Mi...> ;Cancer Cell. 2020 Dec 14
• 4 citations
  Predictive Biomarkers for Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Current Status and Future Directions
  Sheena Bhalla, Deborah B. Doroshow, Fred R. Hirsch> ;Cancer Journal. 2020 Nov 1
• 33 citations
  Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients.
  Douglas Tremblay, Thomas M. Schneider, Sheena Bhalla, Jonathan Feld, Leonard Naymagon, Bo Wang, Vaibhav G. Patel, Tomi Jun, Thomas Jandl, Farah Rahman, Sean T. H. Liu,...> ;Cancer Medicine. 2020 Sep 17
• 114 citations
  Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
  Douglas Tremblay, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina J. Kessler, Sangeetha Venugopal, Iman Makki, Qian Qin, Sirish Dharmapuri, Tomi Jun, Sheen...> ;Blood. 2020 Jul 2
• 65 citations
  Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
  Santiago Thibaud, Douglas Tremblay, Sheena Bhalla, Brittney S Zimmerman, Keith Sigel, Janice Gabrilove> ;British Journal of Haematology. 2020 Jul 1
• 12 citations
  Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.
  Geetanjali R. Kamath, Douglas Tremblay, Alexander Coltoff, Jessica Caro, Guido Lancman, Sheena Bhalla, Vesna Najfeld, John Mascarenhas, Emanuela Taioli> ;Carcinogenesis. 2019 Jul 4
• 1 citations
  Differences in the clinical and genetic profile of Hispanic and non-Hispanic acute myeloid leukemia patients
  Geetanjali R. Kamath, Douglas Tremblay, Alexander Coltoff, Jessica Caro, Guido Lancman, Sheena Bhalla, Vesna Najfeld, John Mascarenhas, Emanuela Taioli> ;Leukemia Research. 2019 Feb 1
• 5 citations
  Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid Malignancies.
  Kelsey Sokol, Douglas Tremblay, Sheena Bhalla, Raajit K. Rampal, John Mascarenhas> ;Oncology. 2018 May 15
• 6 citations
  Implications of Mutation Profiling in Myeloid Malignancies—PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia
  Douglas Tremblay, Kelsey Sokol, Sheena Bhalla, Raajit K. Rampal, John Mascarenhas> ;Oncology. 2018 Apr 15
• 9 citations
  Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions
  Sheena Bhalla, Douglas Tremblay, John Mascarenhas> ;Clinical Lymphoma, Myeloma & Leukemia. 2016 Sep 1
• 27 citations
  Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid
  Sheena Bhalla, Deval D. Joshi, Shaminder S. Bhullar, Daniel Kasuga, Yeonhee Park, Christine N. Kay> ;The British Journal of Ophthalmology. 2013 Jul 1
• Join now to see all